ICD-10 Coding for Lymphoblastic Leukemia(C91.0, C91.00, C91.00A)
Explore the ICD-10 coding guidelines for acute lymphoblastic leukemia (ALL), including remission status codes and documentation requirements.
Complete code families applicable to Lymphoblastic Leukemia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C91.00 | Acute lymphoblastic leukemia not having achieved remission | Use when the patient has not achieved remission post-treatment. |
|
| C91.01 | Acute lymphoblastic leukemia, in remission | Use when the patient is in complete remission. |
|
| C91.02 | Acute lymphoblastic leukemia, in relapse | Use when the patient experiences a relapse. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutLymphoblastic Leukemia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Lymphoblastic Leukemia.
Omitting genetic marker documentation.
Impact
Clinical: Incomplete clinical picture., Regulatory: Potential non-compliance with coding standards., Financial: Possible denial of claims.
Mitigation
Ensure genetic markers are documented in the patient's record., Review lab reports for genetic findings.
Using C91.0 without specifying remission status.
Impact
Reimbursement: Incorrect coding can lead to improper reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Query for specific remission status: not achieved, in remission, or in relapse.
Remission Status Documentation
Impact
Inadequate documentation of remission status can lead to audit issues.
Mitigation
Implement regular documentation audits and training for clinical staff.